|
1
|
Dunn GP, Rinne ML, Wykosky J, Genovese G,
Quayle SN, Dunn IF, Agarwalla PK, Chheda MG, Campos B, Wang A, et
al: Emerging insights into the molecular and cellular basis of
glioblastoma. Genes Dev. 26:756–784. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oike T, Suzuki Y, Sugawara K, Shirai K,
Noda SE, Tamaki T, Nagaishi M, Yokoo H, Nakazato Y and Nakano T:
Radiotherapy plus concomitant adjuvant temozolomide for
glioblastoma: Japanese mono-institutional results. PLoS One.
8:e789432013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fiorica F, Carau B, Ursino S and Cartei F:
Radiotherapy plus concomitant and adjuvant temozolomide for
unresectable glioblastoma: A retrospective analysis of our
experience. Radiother Oncol. 81:S297. 2006.
|
|
5
|
Hargreaves SJ, Williams M, Liu Z, et al:
Survival in patients receiving radiotherapy plus concomitant and
adjuvant temozolomide (RCAT) for glioblastoma (GBM). Int J Radiat
Oncol Biol Phys. 78:S281–S282. 2010. View Article : Google Scholar
|
|
6
|
He W, Li X, Xu S, Ai J, Gong Y, Gregg JL,
Guan R, Qiu W, Xin D, Gingrich JR, et al: Aberrant methylation and
loss of CADM2 tumor suppressor expression is associated with
human renal cell carcinoma tumor progression. Biochem Biophys Res
Commun. 435:526–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang S, Yan HL, Tao QF, Yuan SX, Tang GN,
Yang Y, Wang LL, Zhang YL, Sun SH and Zhou WP: Low CADM2 expression
predicts high recurrence risk of hepatocellular carcinoma patients
after hepatectomy. J Cancer Res Clin Oncol. 140:109–116. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takai Y, Irie K, Shimizu K, Sakisaka T and
Ikeda W: Nectins and nectin-like molecules: Roles in cell adhesion,
migration, and polarization. Cancer Sci. 94:655–667. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Murakami Y: Involvement of a cell adhesion
molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci.
96:543–552. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang GM, Xu SP, Dhir R, Chandran U,
O'Keefe DS, Greenberg NM and Gingrich JR: Hypoexpression and
epigenetic regulation of candidate tumor suppressor gene
CADM-2 in human prostate cancer. Clin Cancer Res.
16:5390–5401. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cody NA, Shen Z, Ripeau JS, Provencher DM,
Mes-Masson AM, Chevrette M and Tonin PN: Characterization of the
3p12.3-pcen region associated with tumor suppression in a
novel ovarian Cancer cell line model genetically modified by
chromosome 3 fragment transfer. Mol Carcinog. 48:1077–1092. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lake SL, Coupland SE, Taktak AF and Damato
BE: Whole-genome microarray detects deletions and loss of
heterozygosity of chromosome 3 occurring exclusively in
metastasizing uveal melanoma. Invest Ophthalmol Vis Sci.
51:4884–4891. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roy D, Sin SH, Damania B and Dittmer DP:
Tumor suppressor genes FHIT and WWOX are deleted in primary
effusion lymphoma (PEL) cell lines. Blood. 118:e32–e39. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tu YY, Gao XC, Li G, Fu H, Cui D, Liu H,
Jin W and Zhang Y: MicroRNA-218 inhibits glioma invasion,
migration, proliferation, and cancer stem-like cell self-renewal by
targeting the polycomb group gene Bmi1. Cancer Res. 73:6046–6055.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re32016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee MY, Chou CY, Tang MJ and Shen MR:
Epithelial mesenchymal transition in cervical cancer: Correlation
with tumor progression, epidermal growth factor receptor
overexpression, and snail up-regulation. Clin Cancer Res. 14:47–43.
2008. View Article : Google Scholar
|
|
19
|
Kuramochi M, Fukuhara H, Nobukuni T, Kanbe
T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura
T, et al: TSLC1 is a tumor-suppressor gene in human
non-small-cell lung cancer. Nat Genet. 27:427–430. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fukuhara H, Kuramochi M, Fukami T,
Kasahara K, Furuhata M, Nobukuni T, Maruyama T, Isogai K, Sekiya T,
Shuin T, et al: Promoter methylation of TSLC1 and tumor
suppression by its gene product in human prostate cancer. Jap J
Cancer Res. 93:605–609. 2002. View Article : Google Scholar
|
|
21
|
Ito T, Shimada Y, Hashimoto Y, Kaganoi J,
Kan T, Watanabe G, Murakami Y and Imamura M: Involvement of TSLC1
in progression of esophageal squamous cell carcinoma. Cancer Res.
63:6320–6326. 2003.PubMed/NCBI
|
|
22
|
Takahashi Y, Iwai M, Kawai T, Arakawa A,
Ito T, Sakurai-Yageta M, Ito A, Goto A, Saito M, Kasumi F, et al:
Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive
lesions of primary breast cancer. Breast Cancer. 19:242–252. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Williams YN, Masuda M, Sakurai-Yageta M,
Maruyama T, Shibuya M and Murakami Y: Cell adhesion and prostate
tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin
superfamily molecule homologous to TSLC1/IGSF4. Oncogene.
25:1446–1453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Raveh S, Gavert N, Spiegel I and Ben-Ze'ev
A: The cell adhesion nectin-like molecules (Necl) 1 and 4 suppress
the growth and tumorigenic ability of colon cancer cells. J Cell
Biochem. 108:326–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nagata M, Sakurai-Yageta M, Yamada D, Goto
A, Ito A, Fukuhara H, Kume H, Morikawa T, Fukayama M, Homma Y, et
al: Aberrations of a cell adhesion molecule CADM4 in renal clear
cell carcinoma. Int J Cancer. 130:1329–1337. 2012. View Article : Google Scholar : PubMed/NCBI
|
